Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monopar Therapeutics | Director | Common Stock | 3.06M | $1.04M | $0.34 | Dec 31, 2023 | Indirect |
Monopar Therapeutics | Director | Common Stock | 30.9K | $10.5K | $0.34 | Dec 31, 2023 | Direct |
Monopar Therapeutics | Director | Restricted Stock Units | 0 | $0.34 | Dec 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | Dec 31, 2023 | 2 | $0 | 4 | Jan 3, 2024 | Director |
MNPR | Monopar Therapeutics | Sep 30, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Director |
MNPR | Monopar Therapeutics | Jun 30, 2023 | 2 | $0 | 4 | Jul 3, 2023 | Director |
MNPR | Monopar Therapeutics | Mar 31, 2023 | 2 | $0 | 4 | Apr 4, 2023 | Director |
MNPR | Monopar Therapeutics | Feb 1, 2023 | 2 | $0 | 4 | Feb 3, 2023 | Director |
MNPR | Monopar Therapeutics | Dec 31, 2022 | 2 | $0 | 4 | Jan 3, 2023 | Director |
MNPR | Monopar Therapeutics | Sep 30, 2022 | 2 | $0 | 4 | Oct 3, 2022 | Director |
MNPR | Monopar Therapeutics | Jun 30, 2022 | 2 | $0 | 4 | Jul 1, 2022 | Director |
MNPR | Monopar Therapeutics | Mar 31, 2022 | 2 | $0 | 4 | Apr 1, 2022 | Director |
MNPR | Monopar Therapeutics | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Director |
MNPR | Monopar Therapeutics | Dec 31, 2021 | 2 | $0 | 4 | Jan 4, 2022 | Director |
MNPR | Monopar Therapeutics | Sep 30, 2021 | 2 | $0 | 4 | Oct 1, 2021 | Director |
MNPR | Monopar Therapeutics | Jun 30, 2021 | 2 | $0 | 4 | Jul 2, 2021 | Director |